Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1234580 | 0.77 | LMNA (0.37) | — | |
| SCHEMBL6158299 | 0.76 | SLC22A6 (0.31) | SLC22A6 | |
| SCHEMBL7106240 | 0.75 | SLC22A6 (0.37) | SLC22A6 | |
| SCHEMBL22207966 | 0.74 | DPP4 (0.37) | SLC22A6 | |
| SCHEMBL22207813 | 0.74 | TP53 (0.31) | SLC22A6 | |
| SCHEMBL1792906 | 0.73 | SLC22A6 (0.36) | SLC22A6 | |
| SCHEMBL6018860 | 0.73 | SLC22A6 (0.36) | SLC22A6 | |
| SCHEMBL31070433 | 0.70 | DPP4 (0.31) | — | |
| SCHEMBL28518010 | 0.68 | — | — | |
| SCHEMBL3875794 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3426718-A1 | METHODS OF FORMING IONICALLY CROSS-LINKED GELS | NORDOVO BIOSCIENCES AS (NO) | 2019-01-16 | — | — | EP | claimed |
| WO-2017153947-A1 | METHODS OF FORMING IONICALLY CROSS-LINKED GELS | NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NO) | 2017-09-14 | — | — | WO | claimed |
| WO-2015103701-A1 | IMPROVED STABILITY OF VISCOUS FLUIDS IN LOW SALINITY ENVIRONMENTS | TRICAN WELL SERVICE, LTD. (CA) | 2015-07-16 | — | — | WO | claimed |
| US-5753094-A | CONSISTS OF WATER, SODIUM TETRABORATE, A BUFFER COMPOUND SELECTED FROM SODIUM PHOSPHATE, POTASSIUM PHOSPHATE, AND 2-(TRIS/HYDROXYMETHYL/METHANE)AMINO-ETHANESULFONIC ACID, AND A CONDUCTIVITY ADJUSTER SUCH AS SODIUM OR POTASSIUM CHLORIDE | BECKMAN INSTRUMENTS, INC. (US) | 1998-05-19 | — | — | US | claimed |
| US-4407961-A | MANAGEMENT OF DIABETES | SANDERS JAMES L | 1983-10-04 | — | — | US | claimed |
| EP-4695346-A1 | POLOXAMER-STABILIZED REAGENTS | Promega Corporation (US) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024216135-A1 | POLOXAMER-STABILIZED REAGENTS | PROMEGA CORPORATION (US) | 2024-10-17 | — | — | WO | disclosed |
| EP-3953374-A1 | COMPOSITIONS AND METHODS FOR ANALYTE DETECTION USING BIOLUMINESCENCE | Promega Corporation (US) | 2022-02-16 | — | — | EP | disclosed |
| EP-3917756-A1 | MICROFLUIDIC EXTRUSION | Embody Inc. (US) | 2021-12-08 | — | — | EP | disclosed |
| EP-3856255-A1 | TREATMENT OF INFECTIONS | Ascendis Pharma A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| EP-3856257-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | Ascendis Pharma A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| WO-2020210658-A1 | COMPOSITIONS AND METHODS FOR ANALYTE DETECTION USING BIOLUMINESCENCE | PROMEGA CORPORATION (US) | 2020-10-15 | — | — | WO | disclosed |
| WO-2013057719-A2 | SAMPLE QUANTIFICATION BY DISC CENTRIFUGATION | NOVARTIS AG (CH) | 2013-04-25 | — | — | WO | disclosed |
| WO-2012027787-A1 | PERFUSION COMPOSITION | ORGAN PERFUSION PTY LIMITED (AU) | 2012-03-08 | — | — | WO | disclosed |
| US-20110065630-A1 | USE OF A OCTREOTIDE AS A THERAPEUTIC AGENT | THERAMETRICS DISCOVERY AG (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20090270306-A1 | Glass Storage | PILKINGTON GROUP LIMITED (GB) | 2009-10-29 | — | — | US | disclosed |
| WO-2003047494-A2 | REVERSE MICELLE COMPOSITIONS AND USES THEREOF | DOR BIOPHARMA INC. (US) | 2003-06-12 | — | — | WO | disclosed |
| US-5753094-A | CONSISTS OF WATER, SODIUM TETRABORATE, A BUFFER COMPOUND SELECTED FROM SODIUM PHOSPHATE, POTASSIUM PHOSPHATE, AND 2-(TRIS/HYDROXYMETHYL/METHANE)AMINO-ETHANESULFONIC ACID, AND A CONDUCTIVITY ADJUSTER SUCH AS SODIUM OR POTASSIUM CHLORIDE | BECKMAN INSTRUMENTS, INC. (US) | 1998-05-19 | — | — | US | disclosed |
| US-4816393-A | Nucleoside triphosphate-dependent 1-methylhydantoinase, a process for obtaining it and the use thereof | BOEHRINGER MANNHEIM GMBH (DE) | 1989-03-28 | — | — | US | disclosed |
| US-4407961-A | MANAGEMENT OF DIABETES | SANDERS JAMES L | 1983-10-04 | — | — | US | disclosed |